THE IMPORTANCE OF THE PHARMACEUTICAL PROFESSIONAL IN THE FOLLOW-UP OF ONCOLOGICAL PATIENTS IN PALLIATIVE CARE: AN INTEGRATIVE REVIEW
DOI:
https://doi.org/10.47820/recima21.v4i11.4378Keywords:
Palliative care consists of care providedAbstract
Palliative care consists of care provided by a multidisciplinary team, which aims to improve the quality of life of patients and their families. In oncology, these precautions are important. In this context, the objective of this article is to highlight the importance of the oncology pharmacist in the area of palliative care. To this end, an integrative review of articles published from 2011 to 2021 in the MEDLINE and VHL databases was conducted. The results demonstrate that the role of pharmacists in the palliative care team has been increasing over the years. It is observed that the early intervention of pharmacists as members of the palliative care team, improves the patient's length of stay, minimizes pain and opioid-induced adverse events, optimizes therapy, and improves the quality of life of patients diagnosed with cancer. Therefore, pharmacists' knowledge should be explored and incorporated into the activities of the palliative care team, since it has been proven to improve care for this population.
Downloads
References
Oliveira MM, Malta DC, Guauche H, Moura L, Silva GA. Estimativa de pessoas com diagnóstico de câncer no Brasil: dados da Pesquisa Nacional de Saúde. Rev Bras Epidemiol. 2015;18(supl.2):146-157.
Braz IFL, Gomes RAD, Azevedo MS, Alves FCM, Seabra DS, Lima FP et al. Análise da percepção do câncer por idosos. Einstein (São Paulo). 2018;16(2):eAO4155.
Cob Guillen E, Cohen Rosenstock, S, Cob Sanchez, A. Obesidad y cáncer. Med. leg. Costa Rica. 2018;35(2):45-53.
Organização Pan-Americano da Saúde (OPAS). Câncer Folha Informativa atualizada em outubro de 2020. [cited 2021 Nov 1]. Available from: https://www.paho.org/pt/topicos/cancer.
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2023 incidência de câncer no Brasil / Instituto Nacional de Câncer José Alencar Gomes da Silva. Rio de Janeiro: INCA; 2022. 162 p
Moroney MR, Lefkowits C. Evidence for integration of palliative care into surgical oncology practice and education. Journal of Surgical Oncology. 2019:1-6.
Charalambous A. Individualized nursing care in câncer care. In: Suhonen R, Stolt M, Papastavrou E, eds. Individualized care; theory, measurement, research and practice. Basel: Springer International Publishing; 2019.
Hermes HR, Lamarca ICA. Cuidados paliativos: uma abordagem a partir das categorias profissionais de saúde. Ciência & Saúde Coletiva. 2013;18(9):2577-2588.
Organização Mundial da Saúde (OMS). WHO expert committe e report: câncer pain relief and palliative care. Geneva, Switzerland: WHO, Update 2002.
Ferrell B. Palliative Care Research: Nursing Response to Emergent Society Needs. NursSci Q. 2010 Jul;23(3):221-5.
Dahlin C, Mazenec P. Building from our past: Celebrating 25 Years of clinical practice in hospice and palliative nursing. J Hosp Palliat Nurs, 2011;13(6):20-28.
Ferrell BR, Temel JS, Temin S, Alesi ER, Baldoni TA, Basch EM et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(1):96-112.
Al-Mahrezi A, Al-Mandhari Z. Palliative Care: Time for Action. Oman medical jornal. 2016;31(3):161-163.
Sociedade Brasileira de Geriatria e Gerontologia (SBGG). Comissão Permanente de Cuidados Paliativos da SBGG. Vamos falar de Cuidados Paliativos. SBGG; 2015. 24 p.
Hui D, Bruera E. Models of integration of oncology and palliative care. Annals of Palliative Medicine. 2015;4(3):89–98.
Silva MJS. Contribuições do farmacêutico para a equipe multiprofissional de terapia antineoplásica. Rev. Bras. Farm. Hosp. Serv. Saúde. 2014;5(3):4-5.
Brasil. Conselho Federal de Farmácia (CFF). Resolução nº 288 de 21 de março de 1996. Dispões sobre a competência legal para o exercício da manipulação de drogas antineoplásicas pelo farmacêutico. Diário Oficial da União. 1996.
Brasil. Conselho Federal de Farmácia (CFF). Resolução nº 585 de 29 de agosto de 2013. Ementa: Regulamenta as atribuições clínicas do farmacêutico e dá outras providências. Diário Oficial da União. 2013.
American Society of Health-System Pharmacists (ASHP). ASHP guidelines on the pharmacist’s role in palliative and hospice care. Am J Health-SystPharm. 2016;73:1351-67.
Mancini R. Implementing a Standardized Pharmacist Assessment and Evaluating the Role of a Pharmacist in a Multidisciplinary Supportive Oncology Clinic. J Support Oncol. 2012;10(3):99-106.
Ma JD, Tran V, Chan C, Mitchell WM, Atayee RS. Retrospective analysis of pharmacist interventions in an ambulatory palliative care practice. J Oncol Pharm Pract. 2016 Dec;22(6):757-765.
Geum MJ. Interprofessional Collaboration Between a Multidisciplinary Palliative Care Team and the Team Pharmacist on Pain Management. Am J Hosp Palliat Care. 2019;36(7):616-622.
Duffy AP, Bemben NM, Li J, Trovato J. Facilitating Home Hospice Transitions of Care in Oncology: Evaluation of Clinical Pharmacists' Interventions, Hospice Program Satisfaction, and Patient Representation Rates. Am J Hosp Palliat Care. 2018;35(9):1181-1187.
Salmany SS, Rayyan M, Dabbous A, Mughrabi A. Descriptive study of clinical pharmacist interventions in adult hospice and palliative care at a comprehensive oncology center in Jordan. J Oncol Pharm Pract. 2021;10781552211040736.
Bernard SA, Keisler MD, Valgus JM, Winzelberg GS. Pharmacist-Led Models of Outpatient Palliative Care J Oncol Pract. 2019;15(9):507-508.
Crul M, Oosterhof P. The oncology pharmacist as part of the palliative treatment team. Int J Pharm Pract. 2020;28(1):92-96.
Yamada M, Matsumura C, Jimaru Y, Ueno R, Takahashi K, Yano Y. Effect of Continuous Pharmacist Interventions on Pain Controland Side Effect Management in Outpatients with Cancer Receiving Opioid Treatments. Biol Pharm Bull. 2018;41(6):858-863.
Gagnon L, Fairchild A, Pituskin E, Dutka J, Chambers C. Optimizing pain relief in a specialized outpatient palliative radiotherapy clinic: contributions of a clinical pharmacist. J Oncol Pharm Pract. 2012;18(1):76-83.
Downloads
Published
License
Copyright (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
